Driehaus Capital Management »

Precigen shares owned by Driehaus Capital Management

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Driehaus Capital Management from 13F filings

Historical chart of Driehaus Capital Management investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Driehaus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.7M 2.0M 3.29

More positions owned by Driehaus Capital Management

Taiwan Semiconductor-sp Adr (TSM)
Crinetics Pharmaceuticals In (CRNX)
Planet Labs Pbc Com Cl A (PL)
Sitime Corp (SITM)
Xenon Pharmaceuticals Adr (XENE)
Icici Bank Ltd- Adr (IBN)
Astera Labs (ALAB)
Cameco Corp Adr (CCJ)
Curtiss-Wright (CW)
Rhythm Pharmaceuticals (RYTM)
Fabrinet Adr (FN)
Guardant Health (GH)
Credo Technology Group Holding (CRDO)
Uranium Energy Corp Adr (UEC)
Sterling Construction Company (STRL)

View all positions for Driehaus Capital Management

Top funds holding Precigen

Patient Capital Management
Tang Capital Management
BlackRock
Vanguard Group
Caption Management
State Street Corporation
Geode Capital Management
Iridian Asset Management
Citadel Advisors
Susquehanna International
Point72 Asset Management
Parkman Healthcare Partners
Driehaus Capital Management
Morgan Stanley
Northern Trust

View all funds holding Precigen